A novel immunodeficiency syndrome as a rare cause of secondary pulmonary alveolar proteinosis: A diagnosis after 5 decades  by Ferreira, Pedro G. et al.
Rev Port Pneumol. 2014;20(5):273--278
www.revportpneumol.org
CASE REPORT
A  novel  immunodeﬁciency  syndrome  as  a rare  cause  of
secondary pulmonary  alveolar  proteinosis:  A diagnosis
after 5  decades
Pedro G. Ferreiraa,∗, Lina Carvalhob, Fernanda Gamboaa
a Pulmonology  Department,  Coimbra  Hospital  and  University  Centre,  Coimbra,  Portugal
b Anatomopathology  Department,  Coimbra  Hospital  and  University  Centre,  Coimbra,  Portugal
Received 11  July  2013;  accepted  22  August  2013
Available  online  13  April  2014
KEYWORDS
Alveolar  Pulmonary
Proteinosis;
Immunodeﬁciency;
Parenchymal  lung
disease;
Systemic  disease  with
lung  involvement
Abstract  Case  report  of  a  male  patient  with  a  ﬁve-decade  follow-up  history  in  a  tertiary  care
hospital distinguished  for  malabsorption  syndrome,  failure-to-thrive,  meningitis  and  recurrent
bacterial, fungal  and  mycobacterial  pulmonary  infections.  Additionally,  he  developed  epider-
modysplasia  verruciformis,  several  in  situ  spinocellular  carcinomas  and  an  uncharacteristic
parenchymal  lung  disease.  Surgical  lung  biopsy  suggested  pulmonary  alveolar  proteinosis  with
ﬁbrotic change.  Retrospectively,  severe  monocytopenia  had  been  overlooked  in  the  past,  as
well as  low  B  and  NK  cell  blood  counts.  Flow  cytometry  conﬁrmed  the  absence  of  the  previous
cell subsets  along  with  an  undetectable  population  of  dendritic  blood  cells.
Dendritic  cell,  monocyte,  B  and  NK  lymphoid  Human  Deﬁciency  Syndrome  (DCMLS)  is  a  novel
rare immunodeﬁciency  described  in  2010,  linked  to  GATA-2  mutation.  This  syndrome  should  be
highlighted  as  a  rare  cause  of  acquired  PAP,  with  a  radiological  pattern  encompassing  potential
ﬁbrotic change.  Failure  to  recognize  monocytopenia  may  impede  the  chance  to  diagnose.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.U.  All  rights
reserved.
PALAVRAS-CHAVE
Proteinose  Alveolar
Pulmonar;
Imunodeﬁciência;
Uma  nova  síndrome  da  imunodeﬁciência  como  causa  rara  de  proteinose  alveolar
pulmonar:  um  diagnóstico  após  5  décadas
Resumo  Relato  de  um  caso  clínico  de  um  doente  do  sexo  masculino  com  um  historial  de  acom-
das,  num  hospital  de  cuidados  terciários,  caracterizado  por  um  sín-Doenc¸a pulmonar panhamento  de  cinco  décaparenquimatosa;
Doenc¸a sistémica
com  envolvimento
pulmonar
drome de  malabsorc¸ão,  insuﬁciência  de  crescimento,  meningite  e  infecc¸ões  pulmonares  bacte-
rianas, fúngicas  e  micobacterianas  recorrentes.  Além  disso,  desenvolveu  epidermodisplasia  ver-
ruciforme,  diversos  carcinomas  espinocelulares  in  situ  e  uma  doenc¸a  pulmonar  parenquimatosa
não deﬁnida.  Uma  biópsia  pulmonar  cirúrgica  sugeriu  uma  Proteinose  Alveolar  Pulmonar  com
alterac¸ões ﬁbróticas.  Em  retrospectiva,  uma  monocitopenia  grave  negligenciada  no  passado,
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bem  como  uma  baixa  contagem  de  células  B  (linfócitos  B)  e  NK  (células  ‘natural  killer’).  Uma
citometria  de  ﬂuxo  conﬁrmou  a  ausência  dos  subconjuntos  de  células  anteriores,  juntamente
com uma  populac¸ão  indetectável  de  células  dendríticas  sanguíneas.
A Síndrome  de  Deﬁciência  Humana  de  células  dendríticas,  monócitos,  linfóides  B  e  NK  é  uma
rara imunodeﬁciência  descrita  recentemente  em  2010  e  relacionada  com  a  mutac¸ão  do  gene
GATA-2. Esta  síndrome  deverá  ser  referida  como  uma  causa  rara  de  PAP  (proteinose  alveolar  pul-
monar) adquirida,  com  um  padrão  radiológico  que  poderá  apresentar  uma  potencial  alterac¸ão
ﬁbriótica.  A  ausência  de  reconhecimento  da  monocitopenia  pode  impedir  a  oportunidade  de
chegar a  este  diagnóstico.
© 2013  Sociedade  Portuguesa  de  Pneumologia.  Publicado  por  Elsevier  España,  S.L.U.  Todos  os
direitos reservados.
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mWe  present  the  case  report  of  a  61-year-old  male  patient
ith  a  ﬁve-decade  history  of  medical  follow-up  in  a  ter-
iary  care  University  Hospital  who  is  a  non-smoker  without
elevant  family  history  or  occupational  exposures.  The  his-
ory  of  the  present  illness  started  at  the  age  of  9,  with  a
iagnosis  of  pulmonary  tuberculosis  (PT)  for  which  standard
ntibacillary  treatment  was  completed.  He  presented  fail-
re  to  thrive  in  his  early  childhood,  and  at  the  age  of  18,  he
as  admitted  twice  in  the  Internal  Medicine  Department  for
iarrhea,  malabsorption  syndrome  and  acute  tracheobron-
hitis.  By  the  age  of  20  he  had  pneumococcal  meningitis,
ut  had  recovered  without  neurological  sequelae.  During  the
ollowing  decade  he  had  further  admissions  for  community-
cquired  pneumonias,  ‘‘middle  lobe  syndrome’’  and  otitis
edia.
At  the  age  of  37  he  was  again  diagnosed  with  PT  and  com-
leted  standard  treatment,  supervised  by  the  Tuberculosis
istrict  Center.  In  his  forties  he  started  presenting  recur-
ent  processes  of  bronchitis  with  isolation  of  Haemophilus
nﬂuenzae  and  Streptococcus  pneumoniae. He  also  started
ermatological  consultations  for  epidermodysplasia  verruci-
ormis  that  gradually  developed  on  his  hands,  upper  limbs,
orso,  and  neck,  and  severe  perineal  condylomas  that  were
epeatedly  treated  with  electrodessication  and  curettage
Fig.  1).  Since  then,  he  has  been  diagnosed  six  times  with
n  situ  cutaneous  spinocellular  carcinoma.  His  skin  biopsies
ypically  revealed  dyskeratotic  spinocellular  carcinomas  and
‘bowenoid  papulosis’’  of  a  verruciform  nature,  with  abnor-
alities  in  the  granulosa  cell  layer  suggesting  infection  by
uman  papillomavirus  (HPV).
At  the  age  of  47,  one  of  his  admissions  to  the  Pulmonology
epartment  was  for  Aspergillus  fumigatus  lung  infection
the  patient  did  not  fulﬁll  the  criteria  for  allergic  bron-
hopulmonary  mycosis).  A  complete  investigation  for  cystic
brosis  was  performed  and,  after  a  borderline  sweat  test,
e  showed  normal  spermogram  and  negative  Cystic  Fibro-
is  Transmembrane  Conductance  Regulator  (CFTR)  genotype
utation  study.
Gradually,  he  started  developing  parenchymal  lung
isease,  initially  with  reticulomicronodular  pattern  with
pper  lobe  predominance  on  chest  radiograph.  In  his  ﬁfties,
omputed  tomography  (CT)  scan  showed  a  septal  thick-
ning  pattern  with  reticulation,  traction  bronchiectasis
nd  micronodulation.  Pulmonary  function  tests  presented
a
w
e
Toderately  severe  restriction  by  spirometry  (Tiffeneau
ndex  of  0.74,  Forced  Vital  Capacity  57.2%,  forced  expi-
atory  volume  in  one  second  52.8%),  corrected  to  normal
y  plethysmographic  lung  volumes  (total  lung  capacity
0.8%,  residual  volume  109.2%),  with  a  moderately  affected
iffusion  capacity  (DLCO  54%),  while  maintaining  satisfac-
ory  blood  gas  analysis  at  room  air  (pO2 80  mmHg,  pCO2
1  mmHg,  SaO2 96%).
At  his  last  admission,  at  the  age  of  61  years,
e  presented  a  more  pronounced  diffuse  interstitial
eticulomicronodular  pattern  and  progressive  emaciation.
e  complained  of  productive  cough  with  high  vol-
me  purulent  sputum  and  worsened  dyspnea  (grade  III
MRC).  High-resolution  chest  CT  showed  a  more  pro-
use  septal  thickening,  micronodular  pattern  of  random
istribution,  ‘‘tree-in-bud’’  images,  along  with  apical
ubpleural  blebs,  linear  ﬁbrotic  lines  and  distortion  of
he  normal  bronchovascular  architecture  (Fig.  2).  Flex-
ble  bronchoscopy  presented  inﬂammatory  changes  of
he  mucosa  and  mucopurulent  sputum.  BAL,  in  the
ontext  of  infection,  showed  a  concordant  neutrophilic
ellular  proﬁle  (860,000  total  cells/mL,  with  84%  neu-
rophils).  The  cytopathological  study  was  negative  and
icrobiological  workup  allowed  for  the  identiﬁcation  of
orynebacterium  species  and  Acinetobacter  baumannii.
erum  immunoglobulins  were  normal,  as  were  comple-
ent  levels  and  serum  angiotensin-converting  enzyme
iters.  There  were  positive  anti-nuclear  antibodies  with
ositive  anti-cytoskeleton  ﬁbers  and  anti-vimentin  antibod-
es,  and  negative  anti-neutrophil  cytoplasmic  antibodies
ANCAs).  His  serological  panel  was  negative  for  syphilis,  B
nd  C  hepatitis  and  Human  Immunodeﬁciency  virus  (HIV)-
/2  infection,  but  presented  high  IgM  and  IgG  titers  for
ytomegalovirus,  Epstein--Barr  and  herpes  simplex  virus-
.
He  underwent  a  multiple-lobe  surgical  lung  biopsy,  which
as  suggestive  of  alveolar  proteinosis  with  some  ﬁbrotic
race.  It  revealed  aspects  of  diffuse  alveolar  occupation
y  eosinophilic,  Periodic-Acid-Schiff  positive  proteinaceous
aterial,  with  a  light  macrophagic  reaction,  together  with
bnormal  lobular  architecture,  diffuse  septal  ﬁbrosis
ith  focal  collagen  deposition  and  some  multinucleate  for-
ign  body  giant  cells  with  cholesterol  crystal  clefts  (Fig.  2).
here  were  no  granulomas.
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iFigure  1  Epidermodysplasia  verrucif
By  this  time  absent  serum  monocytes  and  low  B  and
NK  cell  counts  had  been  acknowledged.  Indeed,  severe
monocytopenia  had  been  ignored  for  years,  as  had  low
B  and  NK  cell  blood  counts  on  previous  blood  workup.
At  this  moment,  suspicion  about  a  possible  immunode-
ﬁciency  syndrome  associated  with  diffuse  parenchymal
lung  disease  was  assessed.  A  peripheral  blood  sample
was  studied  by  a  detailed  ﬂow  cytometry  at  a  His-
tocompatibility  Center  Laboratory  (Fig.  3).  It  revealed
an  almost  complete  absence  of  monocytes  (CD14+,
CD300E+),  B cells  (CD19+CD20+)  and  NK  cells  (CD56+,
CD3−).  Additionally,  there  was  no  detectable  myeloid
or  plasmacytoid  population  of  dendritic  cells  --  DCs  --
(CD16+).
Bone  marrow  biopsy  disclosed  hypocellularity  with
megakaryocytic  dysplasia  and  maturative  abnormalities.
Marrow  immunophenotyping  revealed  very  scarce  mono-
cytes  (0.4%),  mainly  consisting  of  immature  forms  (promono-
cytes),  absence  of  CD34+  B  cell  precursors,  and  scarce
myeloid  DCs  and  absent  plasmacytoid  DCs  or  CD34+  cells
compromised  with  this  lineage.
The  patient  fulﬁlled  the  diagnostic  criteria  for  Den-
dritic  cell, Monocyte,  B  and  NK  Lymphoid  Human  Deﬁciency
(DCML)  Syndrome,  as  suggested  by  Bigley  and  Collin.1,2 He
t
a
a
ms  on  patient’s  hands,  trunk  and  head.
resented  cutaneous  epidermodysplasia  with  several  in  situ
arcinomas;  mycobacterial  infection  --  two  episodes  of  PT;
evere  blood  monocytopenia,  B  cell  and  NK  cell  deﬁciencies;
bsolute  blood  DCs  deﬁciency;  hypocelullar  bone  marrow
ith  megakaryocytic  dysplasia;  and  normal  immunoglobu-
ins.
DCML,  also  known  as  ‘‘autosomic  dominant  and  sporadic
onocytopenia’’3 or  ‘‘MonoMAC’’4, is  a  novel  immu-
odeﬁciency  syndrome,  primarily  described  in  2010  by
inh  and  colleagues.3 It  results  from  one  of  several
nown  GATA-2  mutations5 determining  a  progressive  and
elective  loss  of  bone-marrow  multi-lymphoid  progeni-
ors  --  pluripotent  cells  that  originate  DC,  monocytes  and
ymphoid  cells  --  and  partial  depletion  of  granulocyte-
acrophage  progenitors  (although  sufﬁcient  to  sustain
ranulopoiesis).2
The  associated  deﬁcit  of  DCs  and  the  understanding  of
he  immunoregulatory  mechanisms  were  highlighted  in  2011
y  Bigley.1 DC  depletion  is  associated  with  a  marked  increase
n  fms-like  tyrosine-kinase  ligand  (FLT3L)  and  concomi-
ant  loss  of  regulatory  T  cells,  which  can  contribute  to
uto-immune  phenomena.2,6,7 Remarkably,  despite  the  near
bsence  of  monocytes,  tecidual  macrophages  --  like  alveolar
acrophages  --  are  preserved  but  are  probably  functionally
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Figure  2  Patient’s  parenchymal  lung  disease  --  imaging  and  lung  biopsy.  (A)  Chest  CT  images  with  interlobular  thickening  pattern
with reticulation,  micronodulation  and  small  scattered  areas  of  ground-glass  and  lobular  opacities.  Alveolar  proteinosis  depicted
b rial,  
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cy diffuse  alveolar  ﬂooding  by  eosinophilic  proteinaceous  mate
eposition.
efective,  explaining  the  possible  feature  of  PAP.2 It  has
een  suggested  that  tecidual  macrophages  may  originate
rom  local  proliferation.
This  progressive  form  of  bone  marrow  lymphoid  fail-
re,  at  a  given  point  in  time,  assumes  features  of  a
istinct  form  of  myelodysplasia4 with  composed  deﬁ-
iency  of  monocytes,  B,  NK  and  DCs  subsets,  along  with
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roneness  to  mycobacterial,  fungal  and  viral  infections,
pidermodysplasia  verruciformis  and  in  situ  carcinomas
elated  to  chronic  HPV  infection,  and  the  possible  devel-
pment  of  PAP  in  a  signiﬁcant  number  of  patients.  Cases
ay  be  sporadic  or  of  autosomal  dominant  heredity,
nd  tend  to  present  in  the  third  or  fourth  decades  of
ife  --  although  previous  unnoticed  monocytopenia  might
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RA  novel  immunodeﬁciency  syndrome  
have  been  present  several  decades  earlier  along  with  an
ill-deﬁned  history  of  unusual  infections  starting  at  an  early
age.3
Unlike  monocytopenia,  NK  and  B  cell  deﬁciencies  are  gen-
erally  not  easily  detected  in  regular  blood  counts  due  to  the
preservation  of  peripheral  T  cells.  Patients  tend  to  present
normocellular  or  hypocellular  (89%)  marrows,  always  with
megakaryocyte  dysplasia.4
Severe  perineal  HPV  infection  from  adolescence  is  a
common  feature,  progressing  with  variously  diffuse  epi-
dermodysplasia  verruciformis,  apparently  as  a  result  of
the  combined  monocyte  and  NK  cell  deﬁciencies.8 Weight
loss  and  constitutional  symptoms  are  frequently  reported,3
but  the  natural  history  is  marked  by  prominent  recurrent
infections  by  mycobacteria,  aerobic  bacteria  and  fungus.
Although  not  an  universal  ﬁnding,  mycobacterial  infection  is
seen  in  the  majority  of  patients1 and  possibly  derives  from
defective  phagocytosis  resulting  from  GATA2  mutation,9 as
well  as  from  impairment  of  the  IL-12/INF- axis  induced  by
the  cellular  deﬁciencies.2
In  advanced  disease,  progression  to  acute  myeloblastic
leukemia  is  frequent  and  autoimmune  phenomena  --  lupus-
like  syndrome,  multiple  sclerosis  --  may  also  occur  in  a
fraction  of  patients.3
Regarding  the  emergence  of  parenchymal  lung  disease
in  DCML,  PAP  occurs  in  33%  of  patients  (36%  in  spo-
radic  and  29%  in  autosomal-dominant  patients),  with  a
median  onset  age  of  42  years,  and  without  detectable  anti
granulocyte-macrophage  colony-stimulating  factor  (GM-
CSF)  antibodies.3 The  impossibility  to  perform  anti-GM-CSF
antibody  testing  at  our  Center  is  a  limitation  in  this  case
report.  However,  as  the  patient  fulﬁlled  all  the  diagnostic
criteria  proposed  by  Bigley  and  Collin,  we  can  speculate  that
anti-GM-CSF  antibodies  would  probably  not  be  present  in  this
case  either,  according  to  what  is  reported  on  patients  with
DCML.
It  apparently  results  from  monocyte/macrophage
dysfunction3 with  metabolism  and  phagocytic  impairment
(induced  by  GATA-2  mutations),9 although  some  believe
that  mycobacterial  infection  may  play  a  pathogenetic
role.  Therapeutic  administration  of  GM-CSF  does  not  seem
to  have  a  signiﬁcant  effect,  but  whole-lung  lavage  may
present  moderate  success.3
A  remarkable  aspect  of  this  case  is  that  the  patient’s
diffuse  parenchymal  lung  disease  was  histologically  consis-
tent  with  chronic  PAP  that  evolved  to  ﬁbrosis.  As  already
suggested  by  some  authors,  established  ﬁbrotic  burden
probably  results  from  the  tecidual  reaction  to  long-lasting
subclinical  proteinosis,  although  it  is  possible  that  the  his-
tory  of  recurrent  bacterial  and  mycobacterial  infections  may
have  also  contributed.10 Generally,  PAP  CT  pattern  is  not
strictly  alveolar  as  many  patients  present  a  ‘‘mosaic  atten-
uation  pattern’’  with  ground  glass  opaciﬁcation,  or  airspace
consolidation,  over  a  background  of  thickened  interlobular
septae.11,12 Moreover,  there  are  various  reports  of  pulmonary
ﬁbrosis  of  various  degrees  associated  with  PAP,  sometimes
diagnosed  several  years  after  disease  onset.10--17 In  some
cases  the  onset  of  PAP  was  clearly  established  prior  to
ﬁbrosis,  using  serial  lung  biopsies.15,17 A  review  by  Holbert
regarding  CT  ﬁndings  in  a  small  group  of  patients  with  PAP
found  substantial  ﬁbrosis  in  2  cases.10 Interestingly,  a  recent
paper  from  Ishii  also  found  that  a  marked  cystic  and  intersti-277
ial  appearance  might  be  particularly  related  to  hereditary
r  secondary  forms  of  PAP.18 Thus,  a  lung  ﬁbrotic  pattern
ay  be  encountered  in  the  context  of  chronic  secondary
AP  (sometimes  subclinical),  namely  in  the  context  of  DMCL
yndrome.
Regarding  treatment  options,  hematopoietic  stem  cell
ransplantation  is  seen  as  potentially  curative  for  DMCL
atients,  even  for  subjects  with  established  respiratory
ailure.1,3
This  entity  should  be  considered  as  a  possible  eti-
logy  of  unexplained  persistent  monocytopenia,  high
usceptibility  to  opportunistic  infections  and  simultaneous
pidermodysplasia  verruciformis,  with  possible  develop-
ent  of  secondary  PAP  potentially  progressing  to  ﬁbrotic
hange.  Further  characterization  of  DMCL  syndrome,  stud-
es  addressing  the  pathogenetic  mechanisms  of  interstitial
brosis  in  patients  with  PAP  and  the  different  reactions  of
ung  parenchyma  in  this  disease  will  be  important  in  the  near
uture.
At  the  time  of  this  publication,  arrangements  are  being
ade  to  investigate  the  speciﬁc  GATA-2  mutation  involved  in
his  patient.  Ideally,  genetic  testing  should  always  be  accom-
lished  in  order  to  expand  the  knowledge  of  orphan  diseases
uch  as  DCML.
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